Multiple targets for flecainide action: implications for cardiac arrhythmogenesis

Autor: Salvage, SC, Chandrasekharan, KH, Jeevaratnam, K, Dulhunty, AF, Thompson, AJ, Jackson, AP, Huang, CL-H

Flecainide suppresses cardiac tachyarrhythmias including paroxysmal atrial fibrillation, supraventricular tachycardia and arrhythmic long QT syndromes (LQTS), as well as the Ca(2+) -mediated, catecholaminergic polymorphic ventricular tachycardia (CPV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______109::077b986598b55540bb29a5744fa3cf4e
https://www.repository.cam.ac.uk/handle/1810/265101

Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis.

Autor: Ma WR; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China., Chandrasekharan KH; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom., Nai CS; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China., Zhu YX; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China., Iqbal J; Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Chang S; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China., Cheng YW; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China., Wang XY; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China., Bourantas CV; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom., Zhang YJ; Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou Medical University, Xuzhou, China.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Nov 14; Vol. 9, pp. 1017833. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).

Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: Validation against histology.

Autor: Bajaj R; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK., Eggermont J; Division of Imaging Processing, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., Grainger SJ; Infraredx, Inc., Bedford, MA, USA., Räber L; Department of Cardiology, Bern University Hospital, Bern, Switzerland., Parasa R; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK., Khan AHA; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Costa C; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Erdogan E; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Hendricks MJ; Infraredx, Inc., Bedford, MA, USA., Chandrasekharan KH; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK., Andiapen M; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK., Serruys PW; Faculty of Medicine, National Heart & Lung Institute, Imperial College London, UK., Torii R; Department of Mechanical Engineering, University College London, London, UK., Mathur A; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK., Baumbach A; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK., Dijkstra J; Division of Imaging Processing, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., Bourantas CV; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK; Cardiovascular Devices Hub, Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, UK; Institute of Cardiovascular Sciences, University College London, London, UK. Electronic address: cbourantas@gmail.com.

Publikováno v: Atherosclerosis [Atherosclerosis] 2022 Mar; Vol. 345, pp. 15-25. Date of Electronic Publication: 2022 Jan 29.

Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.

Autor: Salvage SC; Department of Biochemistry, University of Cambridge, Cambridge, UK.; Physiological Laboratory, University of Cambridge, Cambridge, UK., Chandrasekharan KH; Physiological Laboratory, University of Cambridge, Cambridge, UK., Jeevaratnam K; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.; School of Medicine, Perdana University - Royal College of Surgeons Ireland, Serdang, Selangor Darul Ehsan, Malaysia., Dulhunty AF; Muscle Research Group, Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Acton, Australia., Thompson AJ; Department of Pharmacology, University of Cambridge, Cambridge, UK., Jackson AP; Department of Biochemistry, University of Cambridge, Cambridge, UK., Huang CL; Department of Biochemistry, University of Cambridge, Cambridge, UK.; Physiological Laboratory, University of Cambridge, Cambridge, UK.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2018 Apr; Vol. 175 (8), pp. 1260-1278. Date of Electronic Publication: 2017 May 12.